TY - JOUR
T1 - Improving vitamin D testing and supplementation in children with newly diagnosed cancer
T2 - A quality improvement initiative at Rady Children's Hospital San Diego
AU - Shliakhtsitsava, Ksenya
AU - Fisher, Erin Stucky
AU - Trovillion, Erin M.
AU - Bush, Kelly
AU - Kuo, Dennis John
AU - Newfield, Ron S.
AU - Thornburg, Courtney D.
AU - Roberts, William
AU - Aristizabal, Paula
N1 - Funding Information:
National Cancer Institute, Grant Number: K08 CA230306; Dedman Family
Funding Information:
InformationNational Cancer Institute, Grant Number: K08 CA230306; Dedman FamilyWe thank the pediatric hematology/oncology team and the Quality Improvement Committee (Elizabeth Sheldon RN, Lindsay Colliton RN, Sally Steiner RN, Margaret Fitzgerald RN, Teresa Cassidy RN, and Stacey Brown RN) at the Peckham Center for Cancer and Blood Disorders at Rady Children's Hospital. The content is solely the responsibility of the authors. We thank Adam Felton and Jeff Perham for Electronic Medical Record and EPIC support.
Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/11
Y1 - 2021/11
N2 - Background: Vitamin D deficiency and insufficiency have been associated with poorer health outcomes. Children with cancer are at high risk for vitamin D deficiency and insufficiency. At our institution, we identified high variability in vitamin D testing and supplementation in this population. Of those tested, 65% were vitamin D deficient/insufficient. We conducted a quality improvement (QI) initiative with aim to improve vitamin D testing and supplementation among children aged 2–18 years with newly diagnosed cancer to ≥80% over 6 months. Methods: An inter-professional team reviewed baseline data, then developed and implemented interventions using Plan-Do-Study-Act (PDSA) cycles. Barriers were identified using QI tools, including lack of automated triggers for testing and inconsistent supplementation criteria and follow-up testing post supplementation. Interventions included an institutional vitamin D guideline, clinical decision-making tree for vitamin D deficiency, insufficiency and sufficiency, electronic medical record triggers, and automated testing options. Results: Baseline: N = 26 patients, four (15%) had baseline vitamin D testing; two (8%) received appropriate supplementation. Postintervention: N = 33 patients; 32 (97%) had baseline vitamin D testing; 33 (100%) received appropriate supplementation and completed follow-up testing timely (6–8 weeks post supplementation). Change was sustained over 24 months. Conclusions: We achieved and sustained our aim for vitamin D testing and supplementation in children with newly diagnosed cancer through inter-professional collaboration of hematology/oncology, endocrinology, hospital medicine, pharmacy, nursing, and information technology. Future PDSA cycles will address patient compliance with vitamin D supplementation and impact on patients’ vitamin D levels.
AB - Background: Vitamin D deficiency and insufficiency have been associated with poorer health outcomes. Children with cancer are at high risk for vitamin D deficiency and insufficiency. At our institution, we identified high variability in vitamin D testing and supplementation in this population. Of those tested, 65% were vitamin D deficient/insufficient. We conducted a quality improvement (QI) initiative with aim to improve vitamin D testing and supplementation among children aged 2–18 years with newly diagnosed cancer to ≥80% over 6 months. Methods: An inter-professional team reviewed baseline data, then developed and implemented interventions using Plan-Do-Study-Act (PDSA) cycles. Barriers were identified using QI tools, including lack of automated triggers for testing and inconsistent supplementation criteria and follow-up testing post supplementation. Interventions included an institutional vitamin D guideline, clinical decision-making tree for vitamin D deficiency, insufficiency and sufficiency, electronic medical record triggers, and automated testing options. Results: Baseline: N = 26 patients, four (15%) had baseline vitamin D testing; two (8%) received appropriate supplementation. Postintervention: N = 33 patients; 32 (97%) had baseline vitamin D testing; 33 (100%) received appropriate supplementation and completed follow-up testing timely (6–8 weeks post supplementation). Change was sustained over 24 months. Conclusions: We achieved and sustained our aim for vitamin D testing and supplementation in children with newly diagnosed cancer through inter-professional collaboration of hematology/oncology, endocrinology, hospital medicine, pharmacy, nursing, and information technology. Future PDSA cycles will address patient compliance with vitamin D supplementation and impact on patients’ vitamin D levels.
KW - clinical guidelines
KW - pediatric cancer
KW - quality improvement
KW - vitamin D deficiency
KW - vitamin D supplementation
UR - http://www.scopus.com/inward/record.url?scp=85110883244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110883244&partnerID=8YFLogxK
U2 - 10.1002/pbc.29217
DO - 10.1002/pbc.29217
M3 - Article
C2 - 34286891
AN - SCOPUS:85110883244
SN - 1545-5009
VL - 68
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 11
M1 - e29217
ER -